USDFA regulations hit prospects fo Sun and Dr Reddy’s
Interesting question here would be – what are the manufacturing practices/standards that are being questioned from USFDA? If so, why would the investors flock to the smaller companies? Why can they maintain better operational standards? Simply because of the size of the operations?
PS: This piece of news is generic to the Pharma Industry
| Subscribe To Our Free Newsletter |
